However, PTEN (3%), PIK3CA (3%) and ARIDA (3%) mutations have all been reported in Type II serous ovarian carcinomas, they are just more frequent in Type I ovarian cancers [41]. Here, PIK3CA is linked to ovarian carcinoma.